Sponsored

Private equity firms are aggressively competing for Germany’s tech and healthcare success stories but, while currently unloved, the country’s traditional strongholds may also be poised for a comeback.

Regulators and fund managers are adapting to accommodate greater retail investor participation in private markets, say SEI's Ross Ellis and ANZU Research's Steve Unzicker.

As private equity firms return to deal-making, investment in data analytics is consistent across industries, says Michele McHale, partner and private equity practice leader at Plante Moran.

Diversified LP portfolios have historically comprised the bulk of secondaries market dealflow, but not so in 2020, say Evercore senior managing director Nigel Dawn, vice-president Amy Heinemann and associate Richard Cutshall.

Secondaries GPs have had to get more granular in their approach through the pandemic while the competition continues to intensify, says Pomona Capital founder and chief executive Michael Granoff.

With so many options on how to provide liquidity to investors, Northleaf managing director Matthieu Ducharme details the structures available to mid-market GPs and the related pitfalls to avoid.

Buyout and growth capital investors are embracing a broad range of GP-led solutions, say W Capital Partners managing partner and co-founder David Wachter and partners Blake Heston, Todd Miller and Katie Stitch.

The secondaries market universe is growing. ‘To boldly go where no person has gone before,’ participants will be judged on market positioning and applicable returns, say PJT Park Hill managing director Darren Schluter and partner David Perdue.

With GP-led deals taking the spotlight in the secondaries market, Jeff Akers, head of secondaries investments at Adams Street Partners, shares what that could mean for risk-return profiles.

Concentrated GP-led secondaries dominated in 2020, but buyers are seeking diversification once again, says Gerald Cooper, head of Campbell Lutyens’ North America secondaries advisory.